Key Takeaways
- Clinical Bottom Line
- The Geographic Mal-Distribution of Endoscopy
Clinical Bottom Line
| Geographic Stratification | Specialist Access Metric | Screening Consequence |
|---|---|---|
| Metropolitan Centers | High density; massive glut of ambulatory surgery centers. | Wait times for screening colonoscopies generally < 4 weeks. |
| Rural / Frontier Counties | Absolute clinical desert; frequently zero local board-certified gastroenterologists. | Heavy reliance on non-invasive fecal immunochemical testing (FIT) or Cologuard via mail. |
The Geographic Mal-Distribution of Endoscopy
Despite a robust pipeline of graduating advanced fellows, the United States faces a severe, localized shortage of board-certified gastroenterologists. This shortage is not an absolute deficit of absolute numbers, but a crippling disparity in geographical distribution.
The Shift to Fecal Biomarkers in Deserts
Graduating sub-specialists overwhelmingly cluster in affluent metropolitan and suburban zones to maximize RVU generation and maintain proximity to tertiary academic hospital safety nets. This migration leaves massive swathes of the rural Midwest and South entirely devoid of endoscopic access. In these “endoscopy deserts,” the standard 45-year-old colonoscopy screening mandate is physically impossible to execute. Primary care physicians in these regions must aggressively pivot 100% of their screening workflows toward at-home stool DNA testing (Cologuard) or annual FIT testing, heavily reserving the exceptionally rare, distant hospital colonoscopy slots exclusively for symptomatic patients actively bleeding or triggering positive fecal tests.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
